hutchison china meditech prospectus

Hong Kong: Monday, April 15, 2019: Hutchison China MediTech ... if the Offering proceeds (and in a prospectus supplemen...

hutchison china meditech prospectus

Hong Kong: Monday, April 15, 2019: Hutchison China MediTech ... if the Offering proceeds (and in a prospectus supplement for the Offering in ..., ... 2016, Hutchison China MediTech Limited (“Chi‑Med”) (AIM/Nasdaq: HCM) announces that today it has filed the final prospectus relating to ...

相關軟體 Amazon Chime 資訊

Amazon Chime
Amazon Chime 是一種通信服務,可以通過一個您可以信任的安全,易於使用的應用程序轉換在線會議。 Amazon Chime 無縫地在您的設備上工作,以便您可以保持連接。您可以使用 Amazon Chime 進行在線會議,視頻會議,電話,聊天,以及在組織內部和外部共享內容。 Amazon Chime 解放你從任何地方高效地工作. Amazon Chime 使您的在線會議毫不費力。會議開始準時... Amazon Chime 軟體介紹

hutchison china meditech prospectus 相關參考資料
Chi-Med Announces Pricing of US$110 Million Public Offering ...

London: Thursday, January 23, 2020: Hutchison China MediTech ... The final prospectus supplement relating to the Offering will be filed with ...

https://www.chi-med.com

Chi-Med Files Application to List in Hong Kong and ...

Hong Kong: Monday, April 15, 2019: Hutchison China MediTech ... if the Offering proceeds (and in a prospectus supplement for the Offering in ...

https://www.chi-med.com

Final Prospectus Chi-Med

... 2016, Hutchison China MediTech Limited (“Chi‑Med”) (AIM/Nasdaq: HCM) announces that today it has filed the final prospectus relating to ...

https://www.chi-med.com

HCM Stock - Hutchison China Meditech Ltd SEC Filings

This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Hutchison ...

https://sec.report

Hong Kong Listing Chi-Med

Hutchison China MediTech, or Chi-Med, is an innovative biopharmaceutical company which ... Redacted form of the draft prospectus on SEHK's website[link] ...

https://www.chi-med.com

Hutchison China MediTech Limited - SEC.gov

We also include in this prospectus certain financial data regarding our three non-consolidated joint ventures, Shanghai Hutchison Pharmaceuticals, Hutchison ...

https://www.sec.gov

Hutchison China Meditech Ltd Prospectus 424B5 - SEC.report

Hutchison China MediTech Limited. We are offering US$110,000,000 of American depositary shares, or ADSs, representing of our ordinary ...

https://sec.report

Hutchison China MediTech Ltd SEC Registration - SEC.report

Security and exchange commission filings for Hutchison China MediTech Ltd. ... (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Hutchison ...

https://sec.report

SEC Filings Chi-Med

Hutchison China MediTech, or Chi-Med, is an innovative biopharmaceutical company which researches, develops, manufactures and markets pharmaceutical ...

https://www.chi-med.com